Hansa Biopharma AB (publ) (LON:0RC7)
London
· Delayed Price · Currency is GBP · Price in SEK 24.23
-0.15 (-0.62%)
At close: Jun 5, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 130.98 million as of June 12, 2025. Its market cap has decreased by -31.34% in one year.
Market Cap
130.98M
Enterprise Value
190.79M
Revenue
14.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.23
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 2.62M to 130.98M, an increase of 4,903.36%. That is a compound annual growth rate of 25.63%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 168.59B |
| GSK plc | 61.13B |
| Haleon | 35.73B |
| Smith & Nephew | 9.78B |
| ConvaTec Group | 5.99B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.11B |
| Genus | 1.30B |